47th Annual Meeting of the American Society of Clinical Oncology.

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars


Twelve vs. 36 months of adjuvant imatinib as treatment of operable GIST with a high risk of recurrence: Final results of a randomized trial (SSGXVIII/AIO).
Period6 Jun 2011
Event typeOther
SponsorAmerican Society of Clinical Oncology.
LocationChigago, United StatesShow on map
Degree of RecognitionInternational